BERKELEY HEIGHTS, N.J. and RALEIGH, N.C., Sept. 10 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the appointments of Rajagopalan Srinivasan, Ph.D as Vice President, Global Biostatistics and Christopher Gregory, Ph.D as Scientific Affairs-Director.
"I am excited to have Drs. Srinivasan and Gregory, both highly experienced professionals in their respective fields in clinical research, join the Clinsys team," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "Dr. Srinivasan, who will head up our global biostatistics service offering, brings substantial expertise in biostatistics directly relating to our key therapeutic areas of Oncology, Cardiovascular and CNS. Dr. Gregory, who will serve as a senior scientific advisor for our clinical project teams, brings a wealth of direct pharmaceutical research development and academic experience to support our global regulatory and scientific affairs services."
Dr. Srinivasan has over 25 years of experience in biostatistics with
regulated drug industry and medical research, including 10 years working at
the FDA. He has held a number of senior management positions in the drug
development industry, most recently as Vice President, Global Biostatistics
with a global clinical research organization. During his tenure at the FDA,
Dr. Srinivasan provided statistical guidance to regulated industry in each
step of drug development (Pre-IND, IND, End of Phase II, pre-NDA, NDA as
well as post-marketing Phase IV commitments). Dr. Srinivasan has taught
Biostatistics/Statistics at the George Washington University, Washington,
DC and is currently an adjunct Professor of Biostatistics at University of
Virginia, Charlottesville, Virginia. He received his B. Sc. (Honors), M.A.
and M. Phil degrees in Statistics from the University of Madras in India,
his Masters in Biostatistics from Florida State Unive
|SOURCE Clinsys Clinical Research, Inc.|
Copyright©2007 PR Newswire.
All rights reserved